Odyssey Therapeutics, Inc. (ODTX) stock
ODTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026
$18.34−0.64 (-3.37%)
Close on Nov 19, 2026Market cap $881.39MP/E –Yield –
Odyssey Therapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Odyssey Therapeutics's shares outstanding was 30M at Jun 30, 2026.
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 30M | – |
| Q1 FY2026 | Mar 31, 2026 | 6M | – |
| Q2 FY2025 | Jun 30, 2025 | 1M | – |
| Q1 FY2025 | Mar 31, 2025 | 1M | – |
See a number that looks wrong?